EC
Therapeutic Areas
Palisade Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PALI-2108 | Ulcerative Colitis | Phase 2 |
Leadership Team at Palisade Bio
JF
JD Finley
Chief Executive Officer
MJ
Mitch Jones
President & Chief Medical Officer
RW
Ryker Willie
SVP, Finance and Corporate Controller
SS
Sharon Skare
VP, Global Head of Clinical Operations
JI
James Izanec
VP, Head of Clinical Development
JH
Joerg Heyer
Head of Translational Science & Medicine
DJ
Daniel J. Larkins
Head of Global Regulatory Affairs
AP
Adarsh Patel
Head of Chemistry, Manufacturing and Controls (CMC)
RD
Ramesh Donthamsetty
Head of Corporate Development and Investor Relations
DA
Donald A. Williams
Chairman of the Board